Medifast (MED) Total Current Liabilities (2010 - 2026)

Medifast (MED) has 17 years of Total Current Liabilities data on file, last reported at $42.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 30.39% year-over-year to $42.2 million; the trailing twelve-month figure through Mar 2026 stood at $42.2 million (down 30.39% YoY), and the FY2025 full-year result was $43.0 million, down 33.04% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $42.2 million, down from $43.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $188.2 million in Q2 2022 and bottomed at $42.2 million in Q1 2026.
• The 5-year median for Total Current Liabilities is $77.2 million (2024), against an average of $96.5 million.
• The widest annual swing landed in 2022, when Total Current Liabilities climbed 24.93%; it then sank 41.41% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $140.9 million in 2022, then sank by 34.49% to $92.3 million in 2023, then plunged by 30.49% to $64.2 million in 2024, then sank by 33.04% to $43.0 million in 2025, then retreated by 1.81% to $42.2 million in 2026.
• The last three Total Current Liabilities figures came in at $42.2 million (Q1 2026), $43.0 million (Q4 2025), and $46.7 million (Q3 2025), per Business Quant data.

Peer Comparison